Remove Clinical Development Remove Clinical Trials Remove Generic Pharmaceutical Remove HR
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. billion ($3.65

Sales 98